Electromed (ELMD) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,420.00 |
| Dec 31, 2025 | 627.00 |
| Sep 30, 2025 | -1,085.00 |
| Jun 30, 2025 | 490.00 |
| Mar 31, 2025 | 373.00 |
| Dec 31, 2024 | 576.00 |
| Sep 30, 2024 | 1,299.00 |
| Jun 30, 2024 | 2,526.00 |
| Mar 31, 2024 | 706.00 |
| Dec 31, 2023 | 1,977.00 |
| Sep 30, 2023 | -688.00 |
| Jun 30, 2023 | -118.00 |
| Mar 31, 2023 | -173.00 |
| Dec 31, 2022 | -752.00 |
| Sep 30, 2022 | -2,185.00 |
| Jun 30, 2022 | -1,315.00 |
| Mar 31, 2022 | -1,218.00 |
| Dec 31, 2021 | -1,448.00 |
| Sep 30, 2021 | 1,481.00 |
| Jun 30, 2021 | 219.00 |
| Mar 31, 2021 | 181.00 |
| Dec 31, 2020 | -574.00 |
| Sep 30, 2020 | 586.00 |
| Jun 30, 2020 | 183.00 |
| Mar 31, 2020 | 15.00 |
| Dec 31, 2019 | 829.00 |
| Sep 30, 2019 | -1,403.00 |
| Jun 30, 2019 | -3,285.00 |
| Mar 31, 2019 | 1,503.00 |
| Dec 31, 2018 | -201.00 |
| Sep 30, 2018 | -1,333.00 |
| Jun 30, 2018 | -898.00 |
| Mar 31, 2018 | 1,633.00 |
| Dec 31, 2017 | -548.00 |
| Sep 30, 2017 | 576.00 |
| Jun 30, 2017 | -723.00 |
| Mar 31, 2017 | 1,465.00 |
| Dec 31, 2016 | 3,952.00 |
| Sep 30, 2016 | -352.00 |
| Jun 30, 2016 | 970.00 |
| Mar 31, 2016 | 2,915.00 |
| Dec 31, 2015 | 1,847.00 |
| Sep 30, 2015 | 802.00 |